LLY vs. TSLA: Eli Lilly vs. Tesla Stock Comparison
How do Eli Lilly (LLY) and Tesla (TSLA) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Tesla (TSLA) belongs to Consumer Discretionary (Automobiles & Components) — their GICS classifications point to very different parts of the market.
| Profile Item | LLY | TSLA |
|---|---|---|
| Name | Eli Lilly and Company | Tesla, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Consumer Discretionary |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Automobiles & Components |
| GICS Industry | Pharmaceuticals | Automobiles |
| GICS Sub-Industry | Pharmaceuticals | Automobile Manufacturers |
| Market Capitalization | 1,057.35 billion USD | 1,297.74 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | June 1, 1972 | June 29, 2010 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | LLY | TSLA |
|---|---|---|
| Total Return (1Y) | 86.33% | 1.96% |
| Total Return (3Y, Annualized) | 38.69% | 9.33% |
| Total Return (5Y, Annualized) | 36.38% | 7.11% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Tesla (TSLA) has an aggressive beta of 1.82, indicating higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.50 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | LLY | TSLA |
|---|---|---|
| Volatility (1Y, Annualized) | 35.74% | 46.38% |
| Beta (5Y) | 0.50 | 1.82 |
| Max Drawdown (5Y) | -34.48% | -73.63% |
| Avg. Volume (3M) | 3.06M | 45.91M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | LLY | TSLA |
|---|---|---|
| Sharpe Ratio (1Y) | 2.30 | -0.05 |
| Sortino Ratio (1Y) | 4.03 | -0.06 |
Profitability
ROE (TTM)
Eli Lilly (LLY) at 102.29% sits in the top ROE quartile, while Tesla (TSLA) at 4.67% is closer to the peer norm — stronger capital efficiency for LLY.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
102.29%
- LLY
- 102.29%
- Max
- 102.29%
- Q3
- 2.88%
- Median
- -33.17%
- Q1
- -64.41%
- Min
- -157.61%
TSLA
Automobiles & Components industry group
4.67%
- Max
- 45.44%
- Q3
- 12.25%
- Median
- 5.16%
- TSLA
- 4.67%
- Q1
- -15.16%
- Min
- -40.07%
Net Margin (TTM)
Eli Lilly (LLY) at 33.53% converts revenue to bottom-line profit above its industry’s benchmark range, while Tesla (TSLA) at 3.67% keeps roughly the typical share for its industry.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
33.53%
- LLY
- 33.53%
- Max
- 11.21%
- Q3
- 2.65%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -13.58%
TSLA
Automobiles & Components industry group
3.67%
- Max
- 15.50%
- Q3
- 4.28%
- TSLA
- 3.67%
- Median
- 1.21%
- Q1
- -3.28%
- Min
- -14.37%
Operating Margin (TTM)
Eli Lilly (LLY) at 54.22% operates in the top operating margin quartile, ahead of Tesla (TSLA) at 1.41%, which runs around its industry’s norm.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
54.22%
- Max
- 94.41%
- LLY
- 54.22%
- Q3
- 8.92%
- Median
- 0.00%
- Q1
- -119.39%
- Min
- -309.54%
TSLA
Automobiles & Components industry group
1.41%
- Max
- 21.76%
- Q3
- 8.85%
- Median
- 3.80%
- TSLA
- 1.41%
- Q1
- -0.69%
- Min
- -14.77%
Profitability Metrics
| Metric | LLY | TSLA |
|---|---|---|
| ROE (TTM) | 102.29% | 4.67% |
| ROA (TTM) | 20.36% | 1.93% |
| Net Margin (TTM) | 33.53% | 3.67% |
| Operating Margin (TTM) | 54.22% | 1.41% |
| Gross Margin (TTM) | 83.40% | 18.85% |
Growth
Revenue Growth
Eli Lilly (LLY) at 44.70% is around its peer norm for revenue growth, while Tesla (TSLA) at -2.93% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while Tesla (TSLA) at -47.06% is closer to the peer norm — faster per-share earnings growth for LLY.
Growth Metrics
| Metric | LLY | TSLA |
|---|---|---|
| Revenue Growth (YoY) | 44.70% | -2.93% |
| Revenue Growth (3Y CAGR) | 31.69% | 5.19% |
| EPS Growth (YoY) | 95.99% | -47.06% |
| EPS Growth (3Y CAGR) | 51.71% | -33.18% |
Financial Strength
Current Ratio (MRQ)
Tesla (TSLA) at 1.94 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.36 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.36
- Max
- 26.16
- Q3
- 12.25
- Median
- 5.88
- Q1
- 2.81
- LLY
- 1.36
- Min
- 0.55
TSLA
Automobiles & Components industry group
1.94
- Max
- 3.69
- Q3
- 2.52
- TSLA
- 1.94
- Median
- 1.79
- Q1
- 1.14
- Min
- 0.06
Debt / Equity (MRQ)
Tesla (TSLA) at 0.18 keeps leverage in the lower quartile, while Eli Lilly (LLY) at 1.62 sits in the higher-leverage quartile.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.62
- Max
- 1.64
- LLY
- 1.62
- Q3
- 0.68
- Median
- 0.16
- Q1
- 0.02
- Min
- 0.00
TSLA
Automobiles & Components industry group
0.18
- Max
- 2.02
- Q3
- 1.15
- Median
- 0.74
- Q1
- 0.28
- TSLA
- 0.18
- Min
- 0.00
Financial Strength Metrics
| Metric | LLY | TSLA |
|---|---|---|
| Current Ratio (MRQ) | 1.36 | 1.94 |
| Debt / Equity (MRQ) | 1.62 | 0.18 |
| Net Debt / EBITDA | 1.10 | -2.55 |
Dividends
Dividend Yield (TTM)
Tesla (TSLA) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a yield of 0.54%, ranking against industry peers normally.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.54%
- LLY
- 0.54%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TSLA
Automobiles & Components industry group
0.00%
- Max
- 3.31%
- Q3
- 1.33%
- TSLA
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Tesla (TSLA) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Eli Lilly (LLY) reports a payout of 21.69%, ranking against industry peers normally.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.69%
- LLY
- 21.69%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TSLA
Automobiles & Components industry group
0.00%
- Max
- 72.06%
- Q3
- 32.59%
- TSLA
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | LLY | TSLA |
|---|---|---|
| Dividend Yield (TTM) | 0.54% | 0.00% |
| Dividend Payout Ratio (TTM) | 21.69% | 0.00% |
Valuation
P/E Ratio (TTM)
Eli Lilly (LLY) at 40.00 is near its industry’s usual P/E ratio, while Tesla (TSLA) at 293.38 sits above its peer range — an unusually expensive price for TSLA’s trailing earnings.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
40.00
- Max
- 84.14
- Q3
- 43.16
- LLY
- 40.00
- Median
- 28.60
- Q1
- 15.80
- Min
- 2.32
TSLA
Automobiles & Components industry group
293.38
- TSLA
- 293.38
- Max
- 46.89
- Q3
- 34.07
- Median
- 21.00
- Q1
- 14.22
- Min
- 0.00
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.27 prices around its industry’s typical P/S ratio, while Tesla (TSLA) at 12.52 clears its benchmark range — TSLA looks notably rich on sales.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.27
- Max
- 70.39
- Q3
- 30.57
- LLY
- 13.27
- Median
- 7.62
- Q1
- 3.50
- Min
- 0.01
TSLA
Automobiles & Components industry group
12.52
- TSLA
- 12.52
- Max
- 3.94
- Q3
- 1.79
- Median
- 0.64
- Q1
- 0.34
- Min
- 0.00
P/B Ratio (MRQ)
Measured against book value, both Eli Lilly (LLY) at 33.96 and Tesla (TSLA) at 14.94 look expensive — each P/B ratio sits above its industry’s benchmark range.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
33.96
- LLY
- 33.96
- Max
- 17.22
- Q3
- 8.05
- Median
- 3.87
- Q1
- 1.75
- Min
- -7.69
TSLA
Automobiles & Components industry group
14.94
- TSLA
- 14.94
- Max
- 4.80
- Q3
- 2.32
- Median
- 1.27
- Q1
- 0.56
- Min
- -1.55
Valuation Metrics
| Metric | LLY | TSLA |
|---|---|---|
| P/E Ratio (TTM) | 40.00 | 293.38 |
| P/S Ratio (TTM) | 13.27 | 12.52 |
| P/B Ratio (MRQ) | 33.96 | 14.94 |
| Free Cash Flow Yield (TTM) | 1.05% | 0.37% |